Table 4.
Ischemic Heart Disease | Total Stroke | Ischemic Stroke | Hemorrhagic Stroke | |
---|---|---|---|---|
HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | |
Trajectory group (1992–2004) | ||||
Group 1 (Low steady) | 1.0 | 1.0 | 1.0 | 1.0 |
Group 2 (Lowering) | 1.18 (0.99–1.39) | 0.99 (0.81–1.22) | 1.03 (0.74–1.44) | 0.79 (0.54–1.16) |
Group 3 (High steady) | 1.14 (0.94–1.38) | 0.95 (0.75–1.21) | 0.96 (0.66–1.42) | 0.68 (0.43–1.09) |
Group 4 (Rise and fall) | 1.31 (1.09–1.57) | 1.01 (0.81–1.26) | 1.00 (0.69–1.44) | 1.05 (0.71–1.56) |
Group 5 (Very high steady) | 1.63 (1.39–1.92) | 1.36 (1.11–1.66) | 1.58 (1.16–2.16) | 1.07 (0.75–1.59) |
Baseline variables (1992–1994) | ||||
Age, year | 1.05 (1.02–1.09) | 1.05 (1.01–1.09) | 1.07 (1.01–1.14) | 1.02 (0.95–1.09) |
Body mass index, kg/m2 | 1.07 (1.05–1.10) | 1.03 (1.00–1.06) | 1.07 (1.02–1.11) | 0.96 (0.91–1.02) |
Alcohol drinking | 0.89 (0.77–1.02) | 1.10 (0.91–1.32) | 1.03 (0.77–1.38) | 1.39 (0.95–2.02) |
Exercise | 0.92 (0.79–1.02) | 0.96 (0.80–1.16) | 0.94 (0.70–1.27) | 1.19 (0.85–1.66) |
Systolic BP, per 10 mmHg | 1.09 (1.06–1.14) | 1.10 (1.03–1.16) | 1.09 (0.99–1.20) | 1.11 (1.00–1.25) |
Serum glucose, per 10 mg/dL | 0.98 (0.94–1.02) | 0.95 (0.91–1.01) | 0.90 (0.83–0.96) | 1.05 (0.96–1.14) |
Total cholesterol, per 10 mg/dL | 1.04 (1.02–1.06) | 1.03 (1.01–1.06) | 1.06 (1.02–1.10) | 1.00 (0.96–1.05) |
Mediators (2002–2004) | ||||
Systolic BP, per 10 mmHg | 1.10 (1.05–1.14) | 1.29 (1.23–1.36) | 1.20 (1.20–1.39) | 1.45 (1.33–1.58) |
Serum glucose, per 10 mg/dL | 1.04 (1.02–1.06) | 1.03 (1.00–1.06) | 1.04 (1.01–1.06) | 1.01 (0.96–1.07) |
Total cholesterol, per 10 mg/dL | 1.04 (1.02–1.06) | 1.01 (0.96–1.04) | 1.04 (1.01–1.07) | 0.98 (0.94–1.02) |
Number of participants | 60,709 | 60,709 | 60,709 | 60,709 |
Number event | 1246 | 795 | 316 | 222 |
AIC | 26,970.28 (DF = 14) | 17,156.18 (DF = 14) | 6773.87 (DF = 14) | 4789.69 (DF = 14) |
AIC—Akaike information criterion; HR—hazard ratio; CI—confidence interval.